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Brain infiltration of leukocytes contributes to the
pathophysiology of temporal lobe epilepsy
Abstract
Clinical and experimental evidence indicates that inflammatory processes contribute to the
pathophysiology of epilepsy, but underlying mechanisms remain mostly unknown. Using
immunohistochemistry for CD45 (common leukocyte antigen) and CD3 (T-lymphocytes), we show here
microglial activation and infiltration of leukocytes in sclerotic tissue from patients with mesial temporal
lobe epilepsy (TLE), as well as in a model of TLE (intrahippocampal kainic acid injection),
characterized by spontaneous, nonconvulsive focal seizures. Using specific markers of lymphocytes,
microglia, macrophages, and neutrophils in kainate-treated mice, we investigated with pharmacological
and genetic approaches the contribution of innate and adaptive immunity to kainate-induced
inflammation and neurodegeneration. Furthermore, we used EEG analysis in mutant mice lacking
specific subsets of lymphocytes to explore the significance of inflammatory processes for
epileptogenesis. Blood- brain barrier disruption and neurodegeneration in the kainate-lesioned
hippocampus were accompanied by sustained ICAM-1 upregulation, microglial cell activation, and
infiltration of CD3� T-cells. Moreover, macrophage infiltration was observed, selectively in the dentate
gyrus where prominent granule cell dispersion was evident. Unexpectedly, depletion of peripheral
macrophages by systemic clodronate liposome administration affected granule cell survival.
Neurodegeneration was aggravated in kainate-lesioned mice lacking T- and B-cells (RAG1-knock-out),
because of delayed invasion by Gr-1� neutrophils. Most strikingly, these mutant mice exhibited early
onset of spontaneous recurrent seizures, suggesting a strong impact of immunemediated responses on
network excitability. Together, the concerted action of adaptive and innate immunity triggered locally
by intrahippocampal kainate injection contributes seizure-suppressant and neuroprotective effects,
shedding new light on neuroimmune interactions in temporal lobe epilepsy.
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Clinical and experimental evidence indicates that inflammatory processes contribute to the pathophysiology of epilepsy, but underlying
mechanisms remain mostly unknown. Using immunohistochemistry for CD45 (common leukocyte antigen) and CD3 (T-lymphocytes),
we show here microglial activation and infiltration of leukocytes in sclerotic tissue from patients with mesial temporal lobe epilepsy
(TLE), aswell as in amodel of TLE (intrahippocampal kainic acid injection), characterized by spontaneous, nonconvulsive focal seizures.
Using specific markers of lymphocytes, microglia, macrophages, and neutrophils in kainate-treatedmice, we investigated with pharma-
cological and genetic approaches the contribution of innate and adaptive immunity to kainate-induced inflammation and neurodegen-
eration. Furthermore, we used EEG analysis in mutant mice lacking specific subsets of lymphocytes to explore the significance of
inflammatory processes for epileptogenesis. Blood–brain barrier disruption and neurodegeneration in the kainate-lesioned hippocam-
pus were accompanied by sustained ICAM-1 upregulation,microglial cell activation, and infiltration of CD3 T-cells. Moreover, macro-
phage infiltration was observed, selectively in the dentate gyrus where prominent granule cell dispersion was evident. Unexpectedly,
depletion of peripheralmacrophages by systemic clodronate liposome administration affected granule cell survival. Neurodegeneration
was aggravated in kainate-lesioned mice lacking T- and B-cells (RAG1-knock-out), because of delayed invasion by Gr-1 neutrophils.
Most strikingly, these mutant mice exhibited early onset of spontaneous recurrent seizures, suggesting a strong impact of immune-
mediated responses on network excitability. Together, the concerted action of adaptive and innate immunity triggered locally by intra-
hippocampal kainate injection contributes seizure-suppressant and neuroprotective effects, shedding new light on neuroimmune
interactions in temporal lobe epilepsy.
Introduction
Experimental and clinical evidence indicates that inflammatory
processes contribute to the pathogenesis of several forms of epi-
lepsy (Turrin and Rivest, 2004; Vezzani and Granata, 2005;
Schultzberg et al., 2007; Fabene et al., 2010). Thus, interactions
between leukocytes and vascular endothelial cells modulate
spontaneous recurrent seizures (SRSs) in a rodent model of tem-
poral lobe epilepsy (TLE) (Fabene et al., 2008). Furthermore,
altered blood–brain barrier (BBB) function and increased ex-
pression of proinflammatory cytokines (Oby and Janigro, 2006;
van Vliet et al., 2007; Vezzani et al., 2008; Friedman et al., 2009)
underscore the activation of inflammatory responses during epi-
leptogenesis. Thus, interleukin-1 (IL-1) and IL-1R are rapidly
upregulated in the brain after seizures (Jankowsky and Patterson,
2001; Ravizza et al., 2006, 2008), whereas IL-1, IL-6, and TNF
(tumor necrosis factor-) are increased in microglia and astro-
cytes in epileptic tissue and may lead to recruitment of adaptive
immune system cells (Nguyen et al., 2002; Vezzani and Granata,
2005; Riazi et al., 2008). Conversely, experimental strategies to
block either CNS or systemic inflammation reduce status epilep-
ticus duration and seizure frequency (Marchi et al., 2009;Maroso
et al., 2010). However, the respective contribution of brain-
resident and peripheral immune cells to epileptogenesis is poorly
understood (Fabene et al., 2008).
In this study, we investigated how interactions between innate
and adaptive immunity contribute to functional and histopatho-
logical reorganization of the hippocampal formation in an exper-
imental model of TLE with hippocampal sclerosis (HS), well
characterized formorpho-functional adaptations underlying sei-
zures (Bouilleret et al., 2000; Straessle et al., 2003; Arabadzisz et
al., 2005; Fedele et al., 2005; LeDuigou et al., 2005, 2008;Heinrich
et al., 2006; Ledergerber et al., 2006; Dugladze et al., 2007; Anto-
nucci et al., 2008). In this model, a single intrahippocampal
kainic acid (KA) injection causes gradual development of an ep-
ileptic focus and onset of SRSs after 2 weeks (Bouilleret et al.,
1999). The lesion, characterized by neurodegeneration in the ip-
silateral hilus and CA1/CA3c regions, extensive astrogliosis, and
pronounced dispersion of dentate gyrus granule cells, is restricted
to the dorsal hippocampus, no damage being evident contralat-
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erally or in any extrahippocampal region, including entorhinal
cortex.
Using immunohistochemistry, we investigated the presence
of immune cells in brain tissue resected from mesial temporal
lobe epilepsy (MTLE) patients with HS and from KA-injected
mice. Next, we characterized with specific markers the time
course of inflammation and activation of major components of
adaptive and innate immunity in KA-treated mice and investi-
gated with pharmacological and genetic approaches their contri-
bution to KA-induced tissue damage and epileptogenesis. In
particular, we analyzed the significance of T-lymphocyte infiltra-
tion for regulating SRS onset, using EEG analysis in various lines
of mutant mice, including RAG1- and RAG2-knock-out (KO)
mice (lacking B- and T-cells) (Mombaerts et al., 1992; Shinkai et
al., 1992), 2-microglobulin-KO (2M-KO) mice (lacking
CD8 T-cells) (Zijlstra et al., 1990), and major histocompatibil-
ity class II-KO (MHCII-KO)mice (lacking CD4 cells) (Madsen
et al., 1999). The results point to complex interactions between
innate and adaptive immune responses in KA-lesioned hip-
pocampus, modulating neuronal damage and SRS onset.
Materials andMethods
An overview of all animal experiments performed is given in Table 1.
Animals. Experiments were performed on 12- to 14-week-old male
wild-type and KO mice weighing 25–35 g (Table 2) bred and housed in
small groups in the animal facility of the Institute of Pharmacology and
Toxicology on a 12 h light/dark cycle with food and water provided ad
libitum. During experiments, they were housed in individual cages. An-
Table 1. Design of experiments performed
Each symbol denotes the time point when a procedure was performed. The number of mice analyzed is indicated in parentheses. For EEG recordings, the fraction represents the number of mice with a successful lesion and correct electrode
placement, which were retained for analysis. See Table 2 for a description of the mouse lines used.
Table 2. List of mice used for experiments
Short name Genetic background Phenotype Supplier
B6, wild type C57BL/6J Control mice for all experiments Harlan (RCC Switzerland)
RAG1-KO C57BL/6-CD45.1/T B6.129S7-Rag 1tmMom/J Lack of B- and T-cells inability to initiate V(D)J rearrangement The Jackson Laboratory
B6-RAG2-KO B6.129S6-Rag2 tm1Fwa N12 Lack of B- and T-cells (B6 background) Taconic Farms
BALB/c-RAG2-KO BALB/c-IL2rg tm1 B6.129S6-Rag2 tm1Fwa Lack of B- and T-cells (BALB/c background) Prof. A. Aguzzi (University of Zurich, Zurich, Switzerland)
2M-KO B6;129P2-B2m tm1Jae Lack of CD8 T-cells Prof. B. Becher (University of Zurich)
MHCII-KO B6-I-A tm1Blt Lack of CD4 T-cells Prof. B. Becher (University of Zurich)
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imal procedures were approved by the Cantonal Veterinary Office of
Zurich (Switzerland). All efforts weremade tominimize animal suffering
and the number of animals used.
Kainic acid injection and electrodes implantation.Mice anesthetized
by inhalation of 2.5–3% isoflurane (Baxter) in oxygen received a
unilateral stereotaxic injection of KA (70 nl, 5 mM; Tocris) or vehicle
into the right CA1 area of the dorsal hippocampus [coordinates with
bregma as reference: anteroposterior, 1.8 mm; mediolateral, 1.6
mm; dorsoventral, 1.9 mm] as described (Bouilleret et al., 1999).
Control mice were treated identically but were injected with vehicle
only (0.9% NaCl).
For EEG recordings, mice were implanted immediately after KA injec-
tion with bipolar electrodes aimed the same coordinates (for details, see
Arabadzisz et al., 2005). A monopolar reference electrode was inserted
over the cerebellum. Electrodes were fixed to the skull with cyanoacrylate
and dental acrylic cement. After surgery, the mice were allowed to re-
cover from anesthesia on a warm pad, injected with 1 mg/kg buprenor-
phine (Temgesic; Essex Chemicals) and then returned to their home cage
with daily monitoring of well-being.
EEG recordings. Intrahippocampal EEG activity was recorded in freely
moving mice connected via a swivel to a digital acquisition system
(AcqKnowledge MP100; Biopac Systems). After 30 min habituation to
the Faraday cage, recordings were taken during 3–4 h at a sampling rate
of 200 Hz. Mice were recorded every other day starting from day 2–6
after KA injection until maximum day 20 (Table 1). Recordings were
taken around midday to minimize potential circadian variations. Data
were analyzed off-line and artifacts attributable to animal movements
were discarded. Paroxysmal events were defined as seizures when they
lasted 20 s and were separated by intervals of at least 3 s. For each
animal, the average frequency and duration SRS was calculated.
Neutrophil depletion. Repeated systemic administration of functional
rat anti-granulocyte receptor-1 (Gr-1) monoclonal antibodies (clone
RB6-8C5; catalog #16-5931; eBioscience) or control IgGs (catalog #16-
4031-85; eBioscience) to KA-lesioned mice was used to deplete neutro-
phils (Stirling et al., 2009). In B6 mice, treatment was started 1 d before
KA injection and repeated three times at 3–4 d intervals until killing at
10 d after KA for histological analysis. In RAG1-KOmice, to avoid infec-
tions after surgery, anti-Gr-1 treatment was started at day 6 after KA and
repeated three times before perfusion/fixation at day 14 after KA. Deple-
tion was verified by Gr-1 staining of neutrophils in the spleen.
Macrophage depletion. Depletion of peripheral macrophages was per-
formed by intraperitoneal administration of clodronate liposomes (Clo-
drolip) (75 g/g body weight in B6 and 25 g/g in RAG1-KO mice).
Empty liposomes were used as control. Clodrolip contains18 2 mg
of clodronate per milliliter (0.5 mol of clodronic acid disodium salt
tetrahydrate, CH2Cl2Na2O6P24H2O). After systemic injection, lipo-
somes are phagocytosed and digested by macrophages, followed by in-
tracellular release and accumulation of clodronate, causing 90%
depletion ofmacrophages within 24–36 h (Seiler et al., 1997). Treatment
was started 1 d before KA injection and repeated twice at 3–4 d interval
until killing at day 10 after KA for histological analysis (Table 1). Efficacy
of the treatment was verified by F4/80 immunostaining of mononuclear
phagocytes in the spleen.
Tissue preparation. Human tissue preparation and storage were de-
scribed previously (Loup et al., 2000). All samples used here were taken
from the same patients and postmortem controls.
Mice were deeply anesthetized with pentobarbital (Nembutal; 60 mg/
kg, i.p.) and perfused transcardially with ice-cold fixative (0.15 M sodium
phosphate buffer, 4% paraformaldehyde, 15% saturated picric acid so-
lution, pH 7.4) as described (Fritschy and Mohler, 1995). Brains were
removed immediately after perfusion, postfixed for 3 h at 4°C, and im-
pregnated overnight with 30% sucrose in PBS for cryoprotection. Trans-
verse 40-m-thick sections were cut from frozen blocks with a sliding
microtome and collected in PBS. Sections were then stored in antifreeze
solution (50 mM phosphate buffer, 15% glucose, 30% ethylene glycol,
sodium azide; pH 7.4) at20°C until use.
Immunoperoxidase staining. Primary antibodies used in this study are
listed in Table 3. Immunoperoxidase staining was performed to visualize
the regional distribution of cellular markers in human tissue (CD45 and
CD3) and KA-treated mice (CD45, CD3, B220, CD68, Gr-1, F4/80), as
well as intercellular cell adhesion molecule (ICAM-1) and BBB leakage
(fibrinogen). Sections were incubated overnight at 4°C with primary
antibodies diluted in Tris buffer, pH 7.4, containing 2% normal goat
serum and 0.2% Triton X-100 (ICAM-1, 1:500; CD3, CD4, CD8, CD45,
B220, Gr-1, F4/80, 1:1000; CD68, 1:2000; Iba-1, 1:3000; fibrinogen,
1:10,000). The presence of IgGs in the tissue was probed by incubation
with biotinylated anti-mouse IgGs, skipping the primary antibody incu-
bation. Sections were washed and incubated for 30 min in biotinylated
secondary antibodies (1:300; Jackson ImmunoResearch), followed by
ABC complex for 30 min (Vectastain Elite kit; Vector Laboratories) and
reaction with diaminobenzidine tetrahydrochloride (Sigma-Aldrich) for
5–15 min in Tris, pH 7.7. Finally, sections were washed thoroughly,
mounted onto gelatin-coated slides, air-dried overnight, dehydrated,
and coverslipped with Eukitt (Erne Chemie).
Immunofluorescence staining. Immunofluorescence staining was per-
formed to compare the cellular distribution of two (or three) markers in
the same tissue section. CD3 T-cells were differentiated by double
staining for either CD4 or CD8. The interactions betweenmicroglial cells
and neutrophils were determined by triple labeling for Gr-1, Iba-1, and
the nucleic acid stain Sytox Green (Invitrogen). Comparative morpho-
logical analysis of microglia and macrophage-like cells in the dentate
gyrus was determined by triple labeling for Iba-1, F4/80, and the neuro-
nal marker NeuN. Free-floating sections were incubated overnight in a
mixture of primary antibodies, followed by washes and incubation in
corresponding goat secondary antibodies coupled to Alexa 488 (1:1000),
Alexa 647 (1:1000), or Cy3 (1:500) for 30 min. Sections were mounted
and coverslipped with fluorescent mounting medium (Dako).
Nissl staining. A 1:6 series of sections was Nissl-stained with cresyl
violet to verify pattern of degeneration induced by KA and the placement
of EEG electrodes.
Table 3. List of primary antibodies
Epitope Host species Catalog # Company Marker of:
Human CD3 Mouse MCA1477 Serotec
CD3 T-cells
Mouse CD3 Hamster 553058 BD Biosciences Pharmingen
Mouse CD4 Rat 553727 BD Biosciences Pharmingen CD4 T helper cells
Mouse CD8a Rat 553027 BD Biosciences Pharmingen Cytotoxic CD8 T-cells
Mouse CD45R/B220 Rat 550286 BD Biosciences Pharmingen B-cells
Mouse Gr-1 Rat 553123 BD Biosciences Pharmingen Neutrophils, some monocytes
Human CD45 (common leukocyte antigen) Mouse M0701 Dako
Leukocytes, microglia
Mouse CD45 Rat 0111D BD Biosciences Pharmingen
Mouse CD68 Rat MCA1957GA Serotec (Activated) microglia
Mouse Iba-1 Rabbit 019-19741 Wako Chemicals Microglia
Mouse F4/80 Rat b6640 Abcam Monocytic lineage (tissue macrophages, microglia)
NeuN Mouse MAB377 Millipore Bioscience Research Reagents Neurons
Mouse ICAM-1 (CD54) Hamster 553250 BD Biosciences Activated endothelial cells
Human fibrinogen Rabbit A0080 Dako Blood–brain barrier leakage
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Image acquisition and processing. Histologi-
cal analysis of cresyl violet and immunoperox-
idase staining was performed by bright-field
microscopy (Zeiss AxioCam) and images ac-
quired with an 8 bit digital color camera con-
trolled by AxioVision 4.5 (Zeiss). Exposure
times were held constant during acquisition of
all images for each experiment.
Sections processed for double and triple im-
munofluorescence staining were visualized by
confocal laser-scanning microscopy (LSM 710
Zen; Zeiss) using a 63 objective [numerical ap-
erture (NA), 1.4] and sequential acquisition of
separate channels. Pinhole was set to 1 Airy unit
and the acquisition parameters set to use the full
dynamic range of photomultipliers. Stacks of im-
ages (1024 1024 pixels; pixel size, 70–100 nm)
spaced by 0.35–0.5 m were acquired and pro-
cessed using Imaris software (Bitplane). For
display, maximal intensity projection images
(10–35 layers) were preparedwith eithermerged
or color-separated channels.
Quantification and densitometry analysis.
T-cells immunoreactive for CD3 (CD3) were
counted in aone-in-six series of sections (three to
four sections permouse) through the dorsal hip-
pocampal formationusing stereologicalmethods
(optical fractionator method). For each animal,
the volume of the granule cell layer was deter-
mined by using Mercator software (Explora
Nova).Theregionof interestwasoutlined ineach
section and the total volume was estimated by
summing the surface area enclosed by all the
traces and multiplying by the section thickness
andthe sampling interval.CD3T-cellswerenot
homogeneously distributed precluding random
sampling using a counting frame. Therefore, all
immunopositive cells were counted at highmag-
nification (63; NA, 1.3) in the sampled region of
interest.Datawere analyzed statisticallybyone-way
ANOVA followed by post hoc Bonferroni’s
multiple-comparison test (GraphPad Prism 5).
Extravasation of CD3 T-cells and neutro-
phils was visualized by differential interference
contrast microscopy, distinguishing between in-
travascular/perivascular and intraparenchymal
cells. In each case investigated, the proportion of
each subpopulationwas determined on a sample
of 50 randomly selected immunopositive cells.
Densitometry measurements of CD68 immu-
noreactivity were performed to assess degree of
microglia activation in the hippocampal forma-
tion. Digital images were acquired using a 12 bit
digital camera. Relative optical density measure-
ments were calibrated with a gray-value density
scale. Backgroundwasmeasured in the thalamus
and subtracted frommeasurements made in the
same section. Data were averaged per region of
interest and animal and were analyzed by two-
way ANOVA followed by Bonferroni’s post hoc
tests. Densitometry analysis of ICAM-1 immu-
noreactivity was performed in 12 bit digital im-
ages from bright microscopy were captured with
a 10 (NA, 0.3) lens. The proportional surface
area occupied by immunopositive pixels selected
by threshold segmentationwasdetermined in the
contralateral and in KA-injected hippocampal
formation and compared statistically (paired t
test).
Figure 1. Leukocyte infiltration in human (A, C) and C57BL/6J (B6) mouse (B, D, E, F ) epileptic tissue. A, A, Low-
magnification view of CD45 immunoreactivity in hippocampal tissue from a postmortem control (A) and resected from a
patient with intractable MTLE (A) depicting the presence of resting and activated microglial cells, respectively, and of
blood vessel-associated and intraparenchymal leukocytes (A, arrowheads). The marked sclerosis of the epileptic tissue is
denoted by the shrinking of the CA1 area. B, B, CD45 immunoreactivity in control and sclerotic CA1 area, with arrowheads
pointing to leukocytes; the boxed areas are enlarged at the bottom. C, C, For comparison, CD45 immunoreactivity in a
mouse with a unilateral intrahippocampal KA injection; the contralateral side (C) is depicted as control. Ipsilaterally (C), a
mixture of activated microglial cells, leukocytes (arrowheads), and large macrophage-like cells (arrows) are evident. The
green and red boxed areas are enlarged at the bottom. D–D, Detection of intraparenchymal CD3 lymphocytes (arrow-
heads) in sclerotic tissue from CA1 (D) and hilus (D) in MTLE patients, but not postmortem control (D). E–E, Selective
infiltration by CD3 lymphocytes in mouse epileptic tissue; in control (saline) (E), no CD3 immunoreactivity was seen. In
KA-treated tissue, CD3 cells were seen first in blood vessels (E) (2 d time point) and later intraparenchymally (E) (14 d
time point). F, Unbiased quantification of CD3 lymphocytes in the KA-lesioned dorsal hippocampal formation, demon-
strating their absence in control mice (Sal) and a significant biphasic increase after KA injection (mean SEM; #p	 0.05
compared with 7 d; **p	 0.01 compared with Sal; n
 6 per group; Bonferroni’s posttest analysis). G, Example of double
immunofluorescence staining for CD3 (green) and CD8 (red) depicting a subset of double-labeled cells in the CA1 region
(arrowheads). Abbreviations: GCL, Granule cell layer; HL, hilus; HS, hippocampal sclerosis; ML, molecular layer; SLM,
stratum lacunosum-moleculare; SP, stratum pyramidale; SR, stratum radiatum. Scale bars: A, 500m; B, C, 20m; D, E,
50m; G, 20m.
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Correlation between number of F4/80 cells and integrity of the dentate
gyrus granule cell layer.The analysis was performed to evaluate the impact
of macrophage depletion on granule cell dispersion. In each section an-
alyzed (four per mouse), the granule cell layer was subdivided into six
segments, in which the average thickness of the
granule cell layer and number of F4/80
macrophage-like cells in the molecular and
granule cell layers were determined. Data were
analyzed statistically using linear regression
analysis to correlate the thickness of the gran-
ule cell layer with the number of F4/80 cells.
Results
Activation of immune cells in human
MTLE and in the KAmouse model
of TLE
Immune cell activation in hippocampal tis-
sue resected from patients with intractable
MTLE and HS was investigated immuno-
histochemically with antibodies against
CD45 (common leukocyte antigen) (Fig.
1A,B). The patients (n
 9) and postmor-
tem controls (n 
 4) have been described
previously (Loup et al., 2000). In every sur-
gical specimen examined (Fig. 1A,B), we
observedprominentactivationofmicroglial
cells, alongwith the presence of immunore-
active leukocytes, either associated with
blood vessels or distributed intraparenchy-
mally inCA1-CA3, hilus, and, to a lesser ex-
tent, dentate gyrus. In comparison, in tissue
from postmortem controls, resting micro-
glial cellswereobserved throughout thehip-
pocampal formation, whereas intravascular
leukocytes were detected only sporadically
(Fig. 1A,B).
These observations in human tissue
were addressed in KA-treated mice to de-
termine the validity of this TLE model for
investigating inflammatory responses in
epilepsy. KA injection induces severe neu-
rodegeneration in the hilus, CA1, and
CA3c along with delayed, but prominent
granule cell dispersion (see Introduction).
In lesioned hippocampal tissue from these
mice, CD45 immunoreactivity revealed
strong microgliosis, along with the pres-
ence of large cells with short ramified
branches in the dentate gyrus molecular
layer and of leukocytes in blood vessels
and in the neuropil (Fig. 1C), like those
seen in human tissue. In the contralateral,
nonlesioned side, a weak staining of rest-
ing microglia was observed (Fig. 1C).
To further characterize these CD45 leu-
kocytes, we performed immunoperoxidase
staining for CD3T-cells and B220B-cells,
both in human and B6 mouse tissue (Fig.
1D,E).AlthoughCD3T-lymphocytesread-
ily were detected in epileptic tissue, includ-
ing blood vessels and brain parenchyma, no
B-cells were observed in our analysis. In hu-
man sclerotic hippocampal tissue resected
from surgery, CD3 cells were seen mostly
within blood vessels. Intraparenchymal infiltration was evident in
seven of the nine samples examined, restricted to the hippocampal
sclerosis, and involved between 9 and 31% of CD3 cells (Fig.
Figure2. Activationof innate immunity inKA-lesionedhippocampal formationofB6mice.A–A, GradualdegenerationofCA1,CA3c,
andhilarneurons,alongwithdentategyrusgranulecelldispersion,as seen inKA-injectedhippocampusbycresyl violet stainingcompared
with control (saline).B–B, CD68 immunoreactivity in sections fromthe samemice, depicting the regular distributionof restingmicroglia
in control (B), with a slight increase in staining around the saline injection site (arrow), and the strong increase in all regions where
neurodegenerationwasevident inKA-treated tissue (B,B).Note thatmicrogliaactivationdoesnotoccur in thedentategyrus, except for
a few isolated cells at late timepoints (B, arrow).C, Densitometric analysis of CD68 immunoreactivity, showing selective increase inareas
of neuronal cell loss compared with saline control. The increase was significant in the pyramidal layer of CA1, CA3a,b, and CA3c, in the
stratumradiatumandoriensofCA1and in thehilus. The relativeoptical density (ROD)aregivenasmeanSEM(*p	0.05, **p	0.01,
***p	0.001,Bonferroni’sposttest;n
11).D,Detectionofactivatedmicroglia(arrow)andmacrophage-likecells(arrowheads)byF4/80
immunostaininginKA-injectedhippocampus.Theboxedareaisenlargedbelowthepanel.E–E,Double-immunofluorescencestainingfor
Iba1 (green) and F4/80 (red) showing the distinctivemorphology ofmicroglial cells andmacrophage-like cells in themolecular layer 14 d
after KA injection; for comparison, the contralateral and ipsilateral stratum-lacunosum-moleculare is also depicted. CA, Cornu ammonis;
DG, dentate gyrus; GCL, granule cell layer; ML, molecular layer; SLM, stratum lacunosum-moleculare; SO, stratum oriens; SP, stratum
pyramidale; SR, stratum radiatum;HL, hilus. Scale bars:A,B,D, 250m; E, 20m.
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1D–D). In KA-treated mice, unbiased quantitative analysis re-
vealed a gradual accumulation of CD3 T-cells (one-way
ANOVA, F(3,17) 
 6.18, p 	 0.0049), reaching a maximum at 2
weeks after injection and remaining present at 4 weeks (Fig. 1F).
Initially, CD3 T-cells were detected within blood vessels (Fig.
1E); at 2–4 weeks, they were found mainly within the neuropil
(Fig. 1E), reaching up to 74% of CD3 cells, as seen by differ-
ential interference contrast microscopy (data not shown). Re-
markably, no CD3 T-cells were detected in saline-treated
control mice (Fig. 1E), as well as extrahippocampally in KA-
treated mice. Double-immunofluorescence staining performed
at 14 d after KA to distinguish CD4 and CD8 cells (Fig. 1G)
(data not shown) revealed that 60–75% T-cells (n 
 4 mice)
present in the hippocampus were CD8, suggesting a preferen-
tial infiltration of cytotoxic T-cells in this model of TLE.
Microglial activationmirrors neurodegeneration in
KA-lesioned hippocampus
CD45 immunoreactivity in KA-treated mice suggested wide-
spread activation of innate immunity, in addition to T-cell infil-
tration. Therefore, we investigated with specific markers the
distribution of cells of the monocytic lineage (microglia and
mononuclear phagocytes). Preliminary experiments (data not
shown) with antibodies to Iba1, CD11b, and CD68 revealed that
CD68 allows best to discriminate between resting and activated
microglia. Systematic analysis of CD68 immunoreactivity re-
vealed a prominent and widespread activation of microglial cells,
which reproduced precisely the pattern of neurodegeneration
seen in adjacent Nissl-stained sections (Fig. 2). Thus, the stron-
gest CD68 immunoreactivity occurred in the pyramidal cell layer
of CA1 and CA3c, followed by stratum radiatum and oriens of
CA1. Little microglia activation was detected in the dentate gran-
ule cell layer andmolecular layer. Compared with saline-injected
controls, no microglia activation was observed in the contralat-
eral hippocampal formation. Neuronal death progressed further
between 2 and 4 weeks after KA (Fig. 2A,A), paralleled by in-
creased CD68 staining intensity (Fig. 2B,B). Therefore, we used
CD68 immunoreactivity to quantify the severity of neurodegen-
eration in KA-treated mice by densitometry analysis at day 14
after KA (Fig. 2C). Two-way ANOVA revealed a significant dif-
ference in CD68 immunoreactivity between KA- and saline-
treatedmice (F(1,120)
 133.3; p	 0.0001), as well as a significant
difference among the regions analyzed (F(7,120) 
 5.151; p 	
0.0001), notably in CA1, CA3, and hilus compared with saline-
treated animals (Fig. 2C), confirming our visual impressions that
the KA-induced lesion is most severe in CA1 and CA3c, but
mostly spares the dentate gyrus and, to a lesser extent, the CA3a,b
region.
Detection of macrophage-like cells in the dentate gyrus
Unexpectedly, CD68 staining did not label macrophage-like cells
exhibiting prominent CD45 immunoractivity in the dentate
gyrus (Fig. 1B). Therefore, we tested antibodies against F4/80, a
marker of a wide variety of mature tissue macrophages. This
marker labeled activated microglial cells in KA-lesioned hip-
pocampus, albeit less distinctly than CD68 (Fig. 2D). Interest-
ingly, however, it strongly stained macrophage-like cells around
the dentate granule cell layer, as seen with CD45 (Fig. 2D, inset).
Double immunofluorescence using antibodies to Iba1 confirmed
that prominent F4/80 immunoreactivity was restricted to this
subset of cells in the dentate gyrus, whereas weak F4/80 staining
was seen also in activated microglia (Fig. 2E). Together, these
observations suggest that dentate gyrus granule cells, which un-
dergo profoundmorphological changes and become dispersed in
this TLE model, are selectively associated with a specific subpop-
ulation of F4/80 cells, possibly representing macrophages de-
rived from peripheral mononuclear phagocytes.
Exacerbation of neurodegeneration in RAG1-knock-out mice
Since RAG1-KOmice lack adaptive immune cells (Mombaerts et
al., 1992), we used them to understand the significance of T-cell
infiltration with regard to activation of innate immunity in the
KA mouse model of TLE. RAG1-KO mice treated with KA were
analyzed at various time points after treatment (Table 1) and
compared with age-matched B6 mice. As seen by cresyl violet
staining and CD68 immunoreactivity (Fig. 3A,B), saline-treated
RAG1-KO mice exhibited no abnormality. Despite the lack of
lymphocytes, stereotaxic surgery did not cause infections in
RAG1-KO mice, suggesting effective protection by innate immu-
Figure 3. Enhanced KA-induced neurodegeneration in RAG1-KO mice. A–A, The general
pattern of neurodegeneration induced by KA was globally similar to wild type, but was most
severe and led to complete destruction by 28 d after KA, as seen by cresyl violet staining.B–B,
CD68 immunoreactivity againmirrored precisely the neurodegeneration. In control (B), a slight
enhancement was seen at the injection site (arrow). C, Densitometric analysis of CD68 immu-
noreactivity, with ROD being normalized to wild type (indicated by a dashed line; two-way
ANOVA, Bonferroni’s posttest; *p	 0.05, **p	 0.01, ***p	 0.001). Error bars indicate SEM.
D–D, Example of amouse with severe degeneration seen at 14 d after KA by Nissl staining (D)
and CD68 immunoreactivity (D); in such case, staining for Gr-1 (D) revealed the presence of
numerous Gr-1-positive neutrophils (arrowheads) in zones of extensive degeneration. For ab-
breviations, see Figure 2. Scale bars: All panels, 250m.
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nity. Nevertheless, on KA injection, RAG1-KO mice showed the
typical lesion pattern and activation ofmicroglial cells induced by
KA, but overall with increased severity relative to wild-type mice
(compare Figs. 3A,B, 2A,B). Thus, quantification of CD68 stain-
ing at 14 d after KA injection revealed a significant increase in
RAG1-KO mice, notably in CA1 and CA3 (two-way ANOVA;
effect of genotype: F(1,158) 
 53.3, p 	 0.0001; effect of region:
F(7,158) 
 14.57, p 	 0.0001) (Fig. 3C). Remarkably, extensive
hippocampal neurodegeneration, including loss of dentate gran-
ule cells was observed 28 d after KA injection (Fig. 3A). At this
time point, the cytoarchitecture of the ipsilateral hippocampus
was characterized by strong gliosis and became almost unrecog-
nizable in some animals. These changes were restricted to the
ipsilateral side, extending into the ventral hippocampus, whereas
no changes were apparent contralaterally. Although these altera-
tions were present in all six mice examined after 28 d, they were
already evident in a subset of mice (4 of 11) at 14 d after KA, in
particular in the CA3 area, which was extensively degenerated
(Fig. 3D). Together, these findings indicated that KA-induced
lesion eventually led to a complete destruction of the ipsilateral
hippocampus in RAG1-KO mice, a feature never seen in wild-
type mice.
Neutrophil infiltration in lesioned RAG1-KOmouse
hippocampus underlies increased neurodegeneration
Tissue vacuolization in KA-treated RAG1-KO mice with exten-
sive neurodegeneration suggested the active participation of im-
mune cells to the destruction of neurons. Staining for Gr-1 was
performed to determine whether neutrophils were involved in
the innate response to KA lesion (Fig. 3).
The Gr-1 epitope is a marker of early my-
eloid lineage commitment expressed on
mature neutrophils, as well as some
monocytes (Fleming et al., 1993).NoGr-1
immunoreactivity was detectable in saline
control wild-type or RAG1-KO mice; on
KA injection, it weakly labeled activated
microglial cells in wild-type mice, but not
macrophage-like cells (data not shown).
Remarkably, in RAG1-KO mice, a popu-
lation of strongly labeled, round cells with
a lobulated nucleus (Fig. 4) was detected
in sections from all animals with extensive
neurodegeneration at 14 and 28 d after
KA, suggesting infiltration of the lesioned
tissue by Gr-1-positive neutrophils (Fig.
3D). Examination of earlier time points
revealed isolated Gr-1-positive cells within
blood vessels up to 10 d after KA, followed
by tissue infiltration onday 14, selectively in
the lesioned tissue. Differential interference
contrastmicroscopy showed that 100%Gr-
1-positive cells were intravascular at 10 d af-
ter KA, and 50–70% extravascular at 14 d.
Importantly, increased neurodegenera-
tion affecting a subset of RAG1-KO
mice coincided with the presence of
Gr-1 neutrophils within the lesioned
tissue (Fig. 3D–D). Conversely, neu-
trophils (identified by their lobulated
nucleus and strong Gr-1 staining) were
never detected in wild-type mice, nei-
ther in brain parenchyma nor in blood
vessels, suggesting activation of chemoattractant signals spe-
cifically in the absence of T-lymphocytes.
Additional insight into the role of neutrophils was gained by
double staining for Gr-1 and Iba1, to label both neutrophils and
microglial cells (Fig. 4). Combined with Sytox Green fluores-
cence to visualize cell nuclei, these experiments confirmed that
Gr-1 cells had lobulated nuclei, identifying themas neutrophils,
and showed that they systematically were surrounded, and even
engulfed, by reactive microglial cells (Fig. 4B,C).
The contribution of Gr-1 neutrophils to the exacerbated
neurodegeneration seen in KA-treated RAG1-KO mice was
tested experimentally by inactivation of circulating neutrophils
on systemic treatment with functional anti-Gr-1 antibody (clone
RB6-8C5) or nonimmune IgGs as control (Fig. 5). Wild-type
mice were treated repeatedly every 3–4 d by intravenous infusion
of 100g of antibodies, starting 1 d before KA injection (Table 1)
andwere examined histologically after 10 d to determinewhether
neutrophil neutralizationduring theacutephaseofKA lesionhadan
influence on neurodegeneration. Because of concerns that neutro-
phil depletion might lead to postoperative infections in RAG1-KO
mice, the anti-Gr-1 treatment was started 6 d after KA treatment
with the aim to prevent the delayed neutrophil invasion of the le-
sioned hippocampus. Mice were treated three more times with in-
activating antibodies and examined 14 d after KA (Table 1).
As detected in Nissl-stained sections, anti-Gr-1 treatment did
not influence the KA-induced lesion in wild-type mice (data not
shown), whereas in RAG1-KOmice, it reduced lesion severity to
wild-type levels (Fig. 5B,B). Infusion of control IgG did not
prevent neutrophil invasion in two of four mice, leading to ex-
Figure 4. Engulfment of Gr-1 neutrophils by activatedmicroglial cells in RAG1-KOmice, as visualized by double immunoflu-
orescence for Gr-1 (red) and Iba1 (green). Nuclei were counterstained with Sytox Green (blue). Images were acquired by confocal
laser-scanning microscopy and depicted as maximal intensity projection of 10–15 layers spaced by 0.5m. A, Representative
image from a B6mouse, stratum radiatum of CA1, 14 d after KA injection, depicting the bushy appearance of activatedmicroglial
cells. The weak Gr-1 staining observed in B6 animals was not detected here because of the laser setting used for these images. B,
C, Images from a RAG1-KO mice 14 d after KA injection. Gr-1 cells (red) were identified as neutrophils based on their lobulated
nucleus, as shown in color-separated images (B, C); the asterisk (*) in B and B indicates a transversally cut capillary; note that
most nuclei belong tomicroglial cells, emphasizing their predominance in the lesioned tissue. Gr-1neutrophilswere surrounded
by one or several activatedmicroglial cells, often strongly labeled for Iba1 (B, arrows), or even engulfed by them (B, arrowheads).
These features are illustrated at highermagnification in C and C, depicting twomicroglial cells establishing direct contacts with a
Gr-1 neutrophil, covering most of its surface. Scale bars: A, B, 20m; C, 10m.
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tensive degeneration (Fig. 5A,A). These
conclusions were confirmed by quantifi-
cation of CD68 immunoreactivity, as
above. In KA-injected wild-type mice,
there was no effect of anti-Gr-1 treatment
(two-way ANOVA; F(1,112) 
 1.24; p 

0.2672) despite significantmain effect of the
regions (F(7,112)
17.59;p	0.0001).How-
ever, post hoc analysis showed that no single
region analyzed differed in CD68 staining
between Gr-1-treated versus control mice
(Fig. 5C). Likewise, comparison of Gr-1-
treated RAG1-KO and wild-type mice re-
vealed no significant difference in CD68
immunoreactivity across lesioned areas
(F(1,64)
 2.72; p
 0.1041) (Fig. 5D), con-
firming that neutralization of neutrophils
was sufficient to prevent exacerbation of the
KA lesion.Effectivedepletionofneutrophils
was confirmedby examinationof spleen tis-
sue stained for Gr-1, as well as brain sec-
tions, in which no Gr-1 neutrophils were
detectable (data not shown).
F4/80macrophages in dentate gyrus
protect granule cells from degeneration
To determine whether additional parame-
ters of innate immune response are acti-
vated by KA treatment in RAG1-KO mice,
the distributionof F4/80macrophage-like
cells in the dentate gyrus was analyzed (Fig.
6). As expected from the prominent granule
cell dispersion seen at day 14 after KA, nu-
merous strongly stained macrophage-like
cells were readily detected in lesioned den-
tate gyrus of RAG1-KO mice, like in wild-type (Fig. 6A,B). Unex-
pectedly, these macrophages were missing in sections from mice
with severe degeneration, affecting the integrity of the granule cell
layer.
To determine the origin of these macrophage-like cells and in-
vestigate whether their presence is causally related to granule cell
dispersion, peripheralmononuclear phagocyteswere depletedusing
repeated systemic treatmentwith clodronate liposomes, first admin-
istered 1 d beforeKA injection and continuing every 3 d until day 10
afterKA(Table 1).These liposomesdonotpass theBBB, resulting in
selective depletion of peripheral mononuclear phagocytes. Longer
treatment was not feasible because of systemic toxicity, and the dose
had to be reduced in RAG1-KOmice (25g/g body weight, instead
of 75 g/g in B6 mice). As control, both untreated mice (injected
with KA only) andmice treated with “empty” liposomes were used;
effectiveness of the treatmentwas verified byF4/80 immunostaining
in the spleen, where a 60–85% reduction of F4/80 cells was ob-
served (data not shown).
Essentially identical results were obtained in wild-type and
RAG1-KO mice, as evaluated 10 d after KA by cresyl violet (data
not shown) and F4/80 immunoperoxidase staining (Fig. 6A,B).
By depleting peripheralmacrophages, clodronate liposome treat-
ment caused a partial reduction of macrophage-like cells in the
dentate gyrus, whereas theKA-induced lesion pattern inCA1 and
CA3 was comparable with that seen in control mice. Overall,
granule cell dispersion was reduced, and in five of eight
clodronate-treated mice, zones of the granule cell layer contain-
ing pyknotic granule cells were observed (Fig. 6A). The reduc-
tion of F4/80 cells was most profound where granule cell
dispersion was absent (granule cell layer width,0.15–0.2 mm)
and where granule cell degeneration occurred (granule cell layer
width,	0.15mm) (Fig. 6E,E), suggesting thatmacrophage-like
cells are required for survival of granule cells in KA-lesioned hip-
pocampal formation. No effect of clodronate liposome treatment
was seen on activatedmicroglial cells, as verified by CD68 immu-
noreactivity (data not shown), suggesting a selective action on
peripheral phagocytic mononuclear cells.
These results from immunoperoxidase staining were substan-
tiated by triple immunofluorescence forNeuN (to visualize gran-
ule cells), Iba1, and F4/80 (Fig. 6C,D). In these images, presence
ofmacrophage-like cells, recognized by strong F4/80 staining and
by their distinctive morphology, was restricted to zones of
marked granule cell dispersion, in whichmicroglial cells were not
activated (Fig. 6C). In contrast, absence ofmacrophage-like cells
coincidedwithmicroglia activation and, in part, with granule cell
degeneration (Fig. 6D,D).
These various conditions typically could be seen within a sin-
gle section. Therefore, to quantify the relationship between F4/
80 cells and granule cell dispersion, we subdivided the granule
cell layer into six segments of equal length, and determined the
mean width of each segment (as an index of granule cell disper-
sion), as well as the number of F4/80 macrophage-like cells
associated with the granule cell layer. Linear regression analysis
with data from four sections per mouse revealed a highly signif-
icant correlation between density of macrophage-like cells and
width of the granule cell layer in both wild-type and RAG1-KO
Figure 5. Depletion of Gr-1 neutrophils by systemic anti-Gr-1 treatment prevents exacerbated neurodegeneration in
RAG1-KO mice. A, A, Representative example of a control RAG1-KO mouse, administered with control IgGs. A depicts
infiltrating Gr1 neutrophils into the KA-lesioned hippocampus and A depicts the corresponding CD68 staining. B, B,
Example of a RAG1-KO mouse treated with anti-Gr-1 antibodies. Nissl staining (B) and CD68 immunoreactivity (B)
illustrate a lesion similar to those seen in B6 mice (Fig. 2). C, Densitometric analysis of CD68 staining at 10 d after KA in
RAG1-KO mice treated with anti-Gr-1 antibodies compared with control, untreated mice (dashed line). D, Densitometric
analysis of CD68 staining in KA-injected RAG1-KO mice treated with anti-Gr-1 antibodies compared with KA-injected B6
mice (dashed lines). In both cases, no single region of interest had significantly different intensity of CD68 immunoreac-
tivity in the two groups. Error bars indicate SEM. Scale bar, 250m.
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mice (Fig. 6E,E). After clodronate liposome treatment, a signif-
icant reduction of both parameters (number ofmacrophages and
granule cell layer thickness) was obtained. Although the correla-
tion coefficient was reduced, it was still statistically significant
(Fig. 6E,E).
Together, these data suggest that F4/
80 macrophage-like cells are of periph-
eral origin and infiltrate the KA-lesioned
hippocampus to selectively reside within
the dentate gyrus. The presence of these
cells correlates with granule cell hypertro-
phy and dispersion, and they appear to be
required for long-term survival of granule
cells in this model of TLE.
Early seizure onset in mutant mice with
impaired adaptive immunity
A distinctive feature of the KA mouse
model of TLE is the delayed onset of SRSs,
which typically arise 2 weeks after KA
injection, as shown previously in Swiss
and NMRI mice (Riban et al., 2002;
Arabadzisz et al., 2005). Here, to confirm
that this delay also occurs in B6 mice, in-
trahippocampal EEG activity was re-
corded in six mice between days 2 and 20
after KA (Table 1). Each mouse was re-
corded every second day during 3–4 h af-
ter 30 min habituation to the recording
chamber. The lesion pattern caused byKA
injection and the placement of intrahip-
pocampal electrodes were verified histo-
logically after the last recording session.
Some mice were discarded when either
parameter was not satisfactory (Table 1).
Finally, recording sessions had to be
ended prematurely in some mice because
of loss of connector.
No SRSs (defined as paroxysmal hip-
pocampal discharges lasting for at least
20 s) were detectable before day 12 after
KA in any of the six B6 mice recorded,
which exhibited only isolated spikes-and-
waves and occasional short paroxysmal
events, lasting a few seconds. Thereafter,
SRSs were detected in every recording ses-
sion, with single events lasting up to 100 s
(Fig. 7A,B). Their frequency was variable
within and between animals with a maxi-
mum of 10 seizures per hour, although
sometimes no seizures occurred for up to
1 h. Typically, long seizures coincided
with behavioral arrest and head nodding.
Next, we investigated whether impaired
adaptive immunity was influencing seizure
onset. Unexpectedly, intrahippocampal
EEG recordings inRAG1-KOmice revealed
the occurrence of characteristic SRSs al-
ready during the first session in all animals
analyzed (starting at day 6 after KA in a first
group of mice and at day 2 in the second
group) (Table 1, Fig. 7C,D). These seizures
lasted up to 300 s and their frequency was
variable, reaching amaximumof 12per hour. The seizures observed
at 2–3d afterKA inRAG1-KOmicewere indistinguishable from the
ones recorded in B6mice at 2–3 weeks after KA.
Based on these results, we wondered whether early seizure onset
was correlatedwith severity of the KA lesion. Therefore, histological
Figure 6. Depletion of peripheralmononuclear phagocytes affects dispersion and survival of dentate gyrus granule cells.A,A,
Effect of clodronate liposome treatmenton thedistributionof F4/80macrophage like-cells in thedentategyrusof representative
RAG1-KOmice. The red and blue boxed areas are enlarged below themain panels.B, For comparison, F4/80macrophages seen
in B6mice are depicted. C,D, Images of triple-immunofluorescence staining in the dentate gyrus against Iba1 (green), F4/80 (red),
and NeuN (blue) of KA-treated RAG1-KO mice. Images were acquired by confocal laser-scanning microscopy and depicted as
maximal intensity projection of 10–15 layers spaced by 0.5m. C, C, In controlmice, 10 d after KA, Iba1 restingmicroglial cells
were recognized contralaterally, by their long and slender processes and faint F4/80-IR (C; arrow). “Alerted” microglial cells were
seen ipsilaterally (arrow), along with strongly labeled F4/80macrophage-like cells characterized by their larger cell body and
short and thick processes (C). Note the preservation of granule cells, which were enlarged and dispersed. D, D, Representative
images fromRAG1-KO KA-injectedmice treatedwith clodronate liposomes. Strongly labeled F4/80macrophageswere conspic-
uously absent; microglial cells were alerted in zones where the granule cell layer was intact (D), whereas numerous activated
microglial cells, with a “bushy” appearance,were seenwhere granule cell degenerationwas evident (D, arrow). E, E, Correlation
between granule cell dispersion and density of F4/80 macrophages in B6 (E) and RAG1-KO (E) mice. Each scatter plot
depicts data from KA-injected mice treated with clodronate liposomes and untreated control mice. Regression analysis
(thickness of granule cell layer versus number of F4/80 cells) revealed in each genotype a significant correlation in both
groups of mice. In addition, effect of clodronate liposome treatment was reflected by significantly reduced thickness of the
granule cell layer and significantly reduced number of F4/80 macrophages, occurring in both genotypes. Scale bars: A,
250m; B, 50m; C, D, 20m.
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changes in KA-injected hippocampus were analyzed by Nissl stain-
ing at the end of the experiments. These observations revealed that 3
of the 10 recorded RAG1-KO mice had a rather mild lesion, with
substantial preservation of the CA3a,b area and moderate granule
cell dispersion,whereas theother7micehada severe lesion, affecting
most of the CA1-CA3 pyramidal layer and leading to prominent
dispersion of the granule cell layer. No mice showed the complete
destruction of the hippocampal formation associated with neutro-
phil invasion (Fig. 2). Nevertheless, frequency of SRSs did not cor-
relate with lesion severity (Fig. 8A,B).
Together, the occurrence of a latent phase of epileptogenesis in
this TLE model appears related to the integrity of the adaptive im-
mune system.Deletion of theRAG1 gene is sufficient to enable early
SRS onset even in mice with a mild lesion, although the mutation
selectively affects maturation of lymphocytes. However, a potential
pitfall of RAG1-KOmice is that this expression of this gene has also
been reported in hippocampus and cerebellum (Mombaerts et al.,
1992). To discard the possibility that early seizure onset was attrib-
utable to the absence of RAG1 in the CNS, we performed a series of
EEG recordings in KA-treated RAG2-KO mice. This gene is func-
tionally homologous to RAG1 but is not expressed in the CNS
(Chun et al., 1991), thereby excluding confounding effects poten-
tially present in RAG1-KOmice.
RAG2-KO mice were available in two different strains (B6 and
BALB/c) (Table 2), allowing us to test for possible strain-related
effects. KA-treated B6-RAG2-KO and BALB/c-RAG2-KO mice
were recorded every second day, starting at days 2–3 after KA injec-
tion and continuing until day 16 (Table 1). As seen in RAG1-KO
mice, SRSs occurred already at days 2–3 after KA injection in all
RAG2-KOmiceanalyzed (Fig. 7E,F), regardlessof strain, reproduc-
ing the shortening of the latent phase seen in RAG1-KOmice. Like-
wise, thepatternof hippocampal damage causedby theKA injection
was comparable in extent and variability in RAG2-KO mice with
that occurring in RAG1-KO mice (Fig. 7G,G). These results dem-
onstrate that lack of RAG1 in the brain was not responsible for early
onset of SRSs after KA treatment.
To determine whether CD4 or CD8 T-cells are differentially
implicated in the abolitionof the latentphaseobserved inRAG1-KO
mice, we performed intrahippocampal EEG recordings in2M-KO
and inMHCII-KOmice, lacking CD8 and CD4 T-cells, respec-
tively (Fig. 8C,D, Table 2).Mice were recorded first at days 2–3 after
KA and successively every second day until days 14–15 in2M-KO
anddays16–20 inMHCII-KOmice (Table1). Similar toRAG1-and
RAG2-KOmice, SRSs were detected already during the first record-
ing session in2M-KOmice.Their frequencywas variable, reaching
up to 20 seizures per hour. Thereafter, however, we observed a
marked reduction of seizure frequency, with the majority of mice
having less than two seizures per hour during the second week of
recordings (Fig. 8C). In these mutants, conspicuous interictal
paroxysmal activity was evident, ranging from isolated spikes-
and-wave to short “seizure-like” episodes typically lasting
5–10 s. Histological analysis revealed that severity of the lesion
in these 2M-KO mice was mostly similar to that seen in B6
mice (Fig. 8C). However, one mouse had a moderate lesion
and twomice a severe lesion, which did not correlate with time
of onset or frequency of SRSs (Fig. 8C).
The analysis of intrahippocampal EEG recording inMHCII-KO
mice reproduced the abolition of the latent phase observed in
RAG1-KOmice.Median seizure frequencywas low,between2and4
SRSs per hour, although twomice with amoderate lesion had up to
10 SRSs per hour (Fig. 8D). Like in 2M-KOmice, short interictal
paroxysmal discharges were conspicuous. Overall lesion severity in
this specific cohort of mice was less than in wild-type mice, which
might have contributed to reduce the incidence of SRSs. Finally,
comparison of SRS duration among the three lines of mutant mice
revealed no significant differences andno change over time after KA
injection (Fig. 8F).
Intrahippocampal KA injection causes local inflammation
and BBB disruption
To determine whether early seizure occurrence in RAG1-KO mice
compared with B6 is attributable to a difference in acute immune-
mediated responses triggered by KA injection, possibly on B-cell
activation in B6mice, we examined the expression of ICAM-1, BBB
integrity, and microglial cell activation at 24 h after KA (Fig. 9). In
both genotypes, ICAM-1 immunoreactivity in brain blood vessels
was increased selectively in lesioned hippocampus relative to the
contralateral side (Fig. 9A,B).Quantification by densitometry using
the same intensity threshold across all samples showed that the pro-
portional area occupied on the ipsilateral side by pixels positive for
ICAM-1wasonaverage240%higher thancontralaterally inB6mice
(contralateral, 6.5 0.3%; ipsilateral, 15.4 0.5%; p	 0.01) and
241% in RAG1-KO mice (contralateral, 7.8  0.3%; ipsilateral,
17.3  0.3%; mean  SD; n 
 3–4 mice). At later time points,
ICAM-1 was most strongly upregulated in glial cells (Fig. 9C,C),
pointing to persistent activation in line with a role in mediating
leukocyte–endothelial cell adhesion required forbrain infiltrationof
T-lymphocytes. Evidence for acute focal BBB leakagewas evidenced
Figure 7. Representative hippocampal EEG recordings during the latent and chronic phases of
TLE.A,B, B6mice during the latent phase (2 d) and at the onset of the chronic phase (14 d) after KA
injection; only isolated spikeswere detectedduring the latent phase.C,D, KA-treatedRAG1-KOmice
at 2 and 14 d after KA; in both cases, SRSs with similar discharge frequency and duration were de-
tected. Theboxedareas in theupper trace (10 s duration) are depictedwithbetter time resolution.E,
F, Recordings in KA-treated RAG2-KO (B6 and BALB/c strains) at 2 d after KA, showing prolonged
seizures. Calibration: horizontal, 5 s; vertical, 20mV.G,G, Histological analysis of RAG2-KOmice by
Nissl staining(G)andCD68 immunoreactivity (G) revealedaneurodegenerationsimilar towild type,
with increased severity, notably in CA3. Scale bar, 250m.
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by fibrinogen immunostaining, revealing accumulation notably in
the lesioned CA1 and CA3c areas in both B6 (data not shown) and
RAG1-KOmice (Fig. 9D,D). Finally, as seen by CD68 immunore-
activity,microglial cells were activated ipsilaterally in the hippocam-
pusanddentategyrus,withoutanyevidence foradifferencebetween
B6 and RAG1-KO mice (Fig. 9E,E). These experiments also re-
vealed that the “background” staining typically produced by IgGs in
tissue from lesioned mice was abolished in RAG1-KO tissue (Fig.
9F,F), reflecting the lackof IgGproduction in the absenceofT- and
B-lymphocytes. Collectively, these results suggest that the acute ef-
fects of KA injection are very similar in B6 and RAG1-KO mice,
inducing a local inflammatory reaction, presumably by triggering
cytokine and chemokine release from activated glial cells.
Discussion
This study demonstrates activation of mul-
tiple components of adaptive and innate
immunity in the KA mouse model of TLE,
leading to local inflammation, BBB disrup-
tion, and infiltrationof leukocytes, aswell as
sustained endothelial andmicroglial cell ac-
tivation in areas of neurodegeneration. Ge-
netic and pharmacological interventions to
prevent T-cell infiltration and deplete pe-
ripheralmacrophagesmarkedlyworsened the
KA-induced lesion. Thus, neurodegeneration
was worsened in RAG1-KO mice on Gr-1
neutrophil infiltration, whereas macrophage
depletion induced granule cell degeneration.
These findings point to aneuroprotective role
of lymphocytes and macrophages infiltrating
the epileptic focus. Functionally, onset of
SRSs shortly after status epilepticus in mice
lacking CD4 and/or CD8 T-cells re-
vealed strong impact of immune-derived
factorsonneuronalnetworks sustaining sei-
zure activity. Together, concerted action of
adaptive and innate immunity provides
neuroprotectiveandseizure-suppressant ef-
fects, shedding new light on the role of neu-
roimmune interactions in TLE with HS.
Validation of the KAmouse model
A distinctive feature of KA-mouse model of
TLE is the focal nature of seizures, which cor-
responds to the strictly unilateral lesion
(Arabadzisz et al., 2005;Duveau and Fritschy,
2010). Furthermore, the temporal gap be-
tween KA-induced status epilepticus and on-
set of SRSs (Riban et al., 2002) allows
separating epileptogenic mechanisms from
excitotoxic action of KA. Thus, activation of
innate immunity and leukocyte infiltration in
KA-treated mice and in tissue from patients
with intractable MTLE (Fabene et al., 2008;
Ravizza et al., 2008) indicate that this mouse
model is relevant for studying the role of neu-
roimmune interactions inMTLEwithHS.
The importance for epileptogenesis of
proinflammatory signaling cascades, as well
as leukocyte–endothelium interactions and
BBB leakage, has been demonstrated in the
pilocarpine model of TLE (Marchi et al.,
2007; Ravizza et al., 2008; Fabene et al.,
2010). Neurodegeneration induced by pilocarpine is more discrete
than in KA-injected mice but extends to extrahippocampal regions
(Curia et al., 2008). However, comparison of in vitro and in vivo
effects of pilocarpine pointed to a role of systemic inflammation in
ictogenesis (Marchi et al., 2007), possibly because of activation of
muscarinic receptors on leukocytes. Furthermore, neutrophils are
also involved, as shown by antibody-mediated suppression (Fabene
et al., 2008), underscoring the importance of systemic inflammation
for ictogenesis. Finally, extravasation of plasma proteins and K
ions contributes to SRSs in pilocarpine-treated rodents (Marchi et
al., 2007, 2010), in line with proepileptogenic effects of BBB disrup-
tion (Friedman et al., 2009).
Figure 8. Scatter plot graphs showing the frequency of intrahippocampal SRSs in B6 (A), RAG1-KO (B), 2M-KO (C), and
MHCII-KO (D) mice over time. Each mouse is represented by a different symbol. The color denotes the severity of the lesion, as
depictedwith a representative image in E (yellow,mild lesion; blue,moderate lesion; red, severe lesion). InD, themouse depicted
with an empty symbol died before tissue collection. At each time point on the x-axis, the median seizure frequency over two to
three consecutive recording sessions is given for everymouse. The horizontal lines denote the overall median.A, Note the absence
of SRSs up to 12–14 d after KA in B6 mice. B, In contrast, SRSs were detected already during the first recording session in all
RAG1-KO mice. The frequency was variable between animals but declined at 14–17 d after KA. C, 2M-KO mice also showed
seizure activity during the first recording session; thereafter, seizure frequency declined regardless of lesion severity, with the
exception of a singlemousewith amild lesion.D, InMHCII-KOmice, SRSs occurred early on,with an apparent correlation between
lesion severity and SRS frequency. E, Cresyl violet staining of the ipsilateral KA-injected hippocampus depicting representative
examples of lesion severity seen after EEG recordings in KA-treatedmice. F, Histogramof average seizure duration (mean SD) in
the three lines ofmutantmice, for three timepoints after KA injection. Two-wayANOVAanalysis revealedno significant difference.
Scale bar, 200m.
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By analogy, since lymphocytes express
ionotropic glutamate receptors (Ganor et al.,
2003), one might hypothesize that intrahip-
pocampal KA injection induces a systemic
inflammation leading to intraparenchy-
mal CD3 T-cell diapedesis. However, this
idea implies that such B-cell-mediated sys-
temic inflammation would not occur in
KA-treated RAG1-KO mice, unlike our
present results. Rather, KA injection causes
similar acute effects in B6 and RAG1-KO
mice, with local upregulation of ICAM-1,
focal BBB disruption, and activation of mi-
croglial cells occurring selectively in the le-
sioned hippocampus.
Together, comparison of the two models
shows that a systemic inflammation is not a
preconditionforonsetofSRSsinrodents.Fur-
thermore, its absence in KA-treated mice
might explain their focal nature,whereas local
inflammation might contribute to model-
specific histopathological features, notably
granule cell dispersion linked to macrophage
invasion in the dentate gyrus.
Significance of microglial
cell activation
Although microglial cell activation reflects
CNS damage and can be deleterious (Rod-
gers et al., 2009; Haselkorn et al., 2010,
Maroso et al., 2010), increasing evidence
indicates that it can also be beneficial by in-
creasing neurotrophic and antiinflamma-
tory factors, clearing debris, and possibly
promoting repair (Batchelor et al., 1999;
Boscia et al., 2009; Rivest, 2009). Here, in
line with the study by Siao et al. (2003),
demonstrating that microglia activation af-
ter intrahippocampal KA injection depends
on tPA (tissue plasminogen activator) re-
lease from injured neurons, several indica-
tions suggest that microglia activation
occurs as a consequence rather than a cause
of KA-induced neurodegeneration. First,
the distribution of activated microglial cells
overlapped perfectly with that of pyknotic
neurons in the chronic, but not acute phase
after KA injection (Fig. 9E,E). Second, aggravated neurodegenera-
tion in RAG1-KOmice,mirrored by increased CD68 immunoreac-
tivity, was dependent on neutrophil infiltration (Fig. 5); particularly
striking was the observation of Gr1 neutrophils engulfed by acti-
vated microglial cells, suggesting an attempt to protect brain tissue
fromneutrophil-mediateddestruction (Fig. 4). Third, in thedentate
gyrus,macrophage depletion induced a clear transition from resting
to “alerted” microglia (Hanisch and Kettenmann, 2007) in the ab-
sence of granule cell death,whereas activatedmicrogliawere seenon
granule cell degeneration (Fig. 6D); of note, denervation of granule
cells on lesion of the perforant pathway induces microglial cell acti-
vation without causing cell loss in the dentate gyrus (Nielsen et al.,
2009). Therefore,microglial cell activation likely is triggered by neu-
rodegeneration in this TLEmodel. However, the lack of correlation
between SRS frequency/duration and lesion severity suggests that
microglial cells do not contribute directly to SRS generation.
Blood-borne macrophages infiltrate the molecular layer of
the lesioned hippocampus
The presence of strongly labeled CD45 and F4/80
macrophage-like cells in the dentate gyrus raised questions
about their identity, origin, and function. They were distinct
from microglial cells based on differential CD68 staining and
morphology, but belong to the same lineage and therefore
likely represent mononuclear phagocytic cells. Previous stud-
ies have shown macrophage infiltration into the dentate gyrus
after denervation (Babcock et al., 2003; Fux et al., 2008). Here,
the reduction of macrophage-like cells, but not microglia, af-
ter systemic clodronate liposome treatment is the strongest
argument in favor of their peripheral origin. Finally, decreased
dispersion and even partial degeneration of dentate granule
cells on decreasedmacrophage brain penetration strongly sug-
gested a neuroprotective role of macrophages for granule cells.
Figure 9. KA injection causes a local inflammatory response in both B6 and RAG1-KO mice, with overexpression of ICAM-1 in
vascular endothelium, focal BBB disruption, and microglia activation. A–C, Comparison of ICAM-1 immunoreactivity in B6 and
RAG1-KOmice in the ipsilateral (ipsi) (KA-injected) and contralateral (contra) hippocampus, as seen after 1 d (A,A;B,B) and14d
(C,C) after KA injection. Pronounced increase in staining intensity in vascular endotheliumof the lesionedhippocampus is evident
acutely in both genotypes. At 14 d after KA (C, C), ICAM-1 immunoreactivity is increased further, reflecting strong expression in
glial cells.D,D, Staining for fibrinogen reveals focal extravasation in the ispilateral hippocampus and along the needle track in the
overlaying cortex, whereas the contralateral side of the same section shows very little immunoreactivity, as illustrated for a
RAG1-KO mice. Note the relative sparing of the CA2 sector (arrow) and of the dentate gyrus. E, E, Similar acute activation of
microglial cells in the lesioned hippocampal formation, as seen in both genotypes by CD68 staining at 24 h after KA injection. The
background in the section from B6mice is attributable to IgGs in the damaged tissue, as confirmed by incubation of sections with
secondary anti-mouse IgG antibodies (F, F). The absence of IgGs in RAG1-KO mice (devoid of B- and T-lymphocytes) completely
prevents this nonspecific staining. Scale bars: All panels, 100m.
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This beneficial effect of macrophages suggests release of factors
supportingneuronal survival andmigration,butprecisemechanism
of action is unclear. Alternatively, since granule cell dispersion after
KA injection depends on TrkB receptor activation after status epi-
lepticus (Inoue et al., 1998) and on disrupted Reelin signaling (Du-
veau et al., 2010; Haas and Frotscher, 2010), it is conceivable that
macrophages are involved in these processes.
Infiltration of CD3 T-cells in the KA-injected hippocampus
is neuroprotective
In KA-treated mice, absence of T-cells curtails the latent phase of
epileptogenesis, underscoring the relevance of immune system
integrity for protecting against premature seizure activity. Silver-
berg et al. (2010) showed that brief episodes of tonic-clonic
seizure activity are sufficient to trigger CD3 lymphocyte in-
filtration into the neocortex and hippocampus. Here, the likely
driving force behind lymphocyte recruitment in the lesioned hip-
pocampus is the local inflammation evidenced by focal fibrino-
gen infiltration and persistent upregulation of ICAM-1. As
discussed above, leukocyte infiltration implicates functional
changes at the BBB, along with increased expression of cytokines
that facilitate diapedesis into the brain (Engelhardt, 2008). IL-1,
which induces ICAM-1 and MCP-1, is credited primarily for
recruitment of macrophages but also acting as T-cell chemoat-
tractant (Gibson et al., 2004). Accordingly, blockade of IL-1
reduces pilocarpine-induced status epilepticus and BBB leakage
(Marchi et al., 2009) and has been proposed as therapeutic venue
to prevent development of epilepsy (Vezzani and Baram, 2007).
Therefore, recruitment of CD3 T-cells in KA-lesioned hip-
pocampus might represent a secondary outcome of the inflam-
matory response serving to limit activation of innate immunity.
The infiltration of Gr-1 neutrophils in RAG1-KO mice gives
additional credit to this idea.
Onset of SRSs in KA-treated mice depends on integrity of
CD3 T-cell-mediated adaptive immunity
Prolonged bilateral stimulation of the perforant pathway in mice
is sufficient for reproducing key features of MTLE with HS, in-
cluding hippocampal atrophy, mossy fiber sprouting, and SRSs
(Kienzler et al., 2009). Therefore, seizure-induced hippocampal
damage might contribute significantly to the pathophysiology of
MTLE, allowing to disregard potential confounding factors
linked to systemic administration of convulsants such as pilo-
carpine. In contrast, seizure activity in the pilocarpine model of
TLE is associated with inflammatory changes in the CNS vascu-
lature (Fabene et al., 2008; Marchi et al., 2009). Therefore, to
reconcile these outcomes, it is likely that specific factors from the
immune system influence neuronal mechanisms of epileptogen-
esis. This possibility is strongly supported by early SRS onset in
mice lacking subsets of lymphocytes, despite having a similar
local inflammation in the lesioned hippocampus. Furthermore, a
major implication of our results is that synaptic reorganization in
the lesioned hippocampus, notably mossy fiber sprouting, is not
necessary for triggering SRSs. Rather, acute damage caused byKA
injection, including destruction of hilar cells and parvalbumin-
positive interneurons in CA1 and dentate gyrus (Bouilleret et al.,
2000), is sufficient for eliciting SRSs, but their occurrence is pre-
vented by mechanisms dependent on CD3 T-cells.
This interpretation is complicated by the fact that none of the
mutant mice analyzed here can be considered simply as lacking a
subset of T-cells. Rather,multiple cytokines and chemokines pro-
duced by CD4 and CD8 cells to influence the maturation and
production of other cells types are lacking, as well. Furthermore,
the role of IgGs, produced by B-cells and present in lesioned
tissue of B6 mice (Fig. 9F,F), and of MHCII molecules, ex-
pressed for instance by dendritic cells, microglial cells, and mac-
rophages, is not known in the context of epileptogenesis.
Determining which cytokines and chemokines are produced in
wild type, but not in mutant mice after KA injection will be re-
quired to understand the role of local inflammatory mechanisms
for seizure occurrence in TLE.
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